The Mepolizumab Pregnancy Exposure Study: a VAMPSS post marketing surveillance study of Mepolizumab safety in pregnancy (200870 NPSS (Nucala Pregnancy Surveillance Study))First published 13/06/2016 Last updated 09/08/2024 EU PAS number: EUPAS13772StudyFinalised